In colorectal cancer patients, PDCD1LG2 expression is negatively correlated with Crohn’s-like lymphoid reactions, suggesting a possible link between PDCD1LG2-expressing tumor cells and adaptive antitumor immunity (41). Here, PDCD1LG2 is linked to colorectal cancer.